MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia

Lonneke J. Verboon, Askar Obulkasim, Jasmijn D.E. de Rooij, Jenny E. Katsman-Kuipers, Edwin Sonneveld, André Baruchel, Jan Trka, Dirk Reinhardt, Rob Pieters, Jacqueline Cloos, Gertjan J.L. Kaspers, Jan Henning Klusmann, Christian Michel Zwaan, Maarten Fornerod, Marry M. van den Heuvel-Eibrink

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


The most important reason for therapy failure in pediatric acute myeloid leukemia (AML) is relapse. In order to identify miRNAs that contribute to the clonal evolution towards relapse in pediatric AML, miRNA expression profiling of 127 de novo pediatric AML cases were used. In the diagnostic phase, no miRNA signatures could be identified that were predictive for relapse occurrence, in a large pediatric cohort, nor in a nested mixed lineage leukemia (MLL)-rearranged pediatric cohort. AML with MLL- rearrangements are found in 15-20% of all pediatric AML samples, and reveal a relapse rate up to 50% for certain translocation partner subgroups. Therefore, microRNA expression profiling of six paired initial diagnosis-relapse MLL-rearranged pediatric AML samples (test cohort) and additional eight paired initial diagnosisrelapse samples with MLL-rearrangements (validation cohort) was performed. A list of 53 differentially expressed miRNAs was identified of which the miR-106b~25 cluster, located in intron 13 of MCM7, was the most prominent. These differentially expressed miRNAs however could not predict a relapse in de novo AML samples with MLLrearrangements at diagnosis. Furthermore, higher mRNA expression of both MCM7 and its upstream regulator E2F1 was found in relapse samples with MLL-rearrangements. In conclusion, we identified the miR-106b~25 cluster to be upregulated in relapse pediatric AML with MLL-rearrangements.

Original languageEnglish
Pages (from-to)48412-48422
Number of pages11
Issue number30
Publication statusPublished - 2016


  • Acute myeloid leukemia
  • MiR-106b~25
  • MLL
  • Relapse


Dive into the research topics of 'MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this